Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Audiol ; 45(9): 528-36, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17005496

RESUMO

The objective of the study was to investigate the prevalence of congenital and early-onset hearing loss, and the influence of the known risk factors for hearing loss on infants in Jordan and Israel. Subjects were a total of nearly 17,000 infants from both countries, including infants with and without risk factors for hearing loss. The hearing screening protocol included distortion product otoacoustic emission, followed in case of repeated OAE referral or high risk (HR) infant by diagnostic auditory brainstem responses. The results indicate that the prevalence and severity of hearing loss amongst Jordanian infants (1.37%) is remarkably higher as compared to the Israeli infants (0.48%). The overall prevalence of bilateral SNHL was seven times more in the Jordanian infants, 18 times in non-risk, and three times in the HR infants relative to the Israeli infants. Risk factors including family history, hyperbilirubinemia, bacterial meningitis, and associated syndromes were more prevalent amongst Jordanian infants. This unique study underscores the importance of sharing and exchanging information to create empirical data to guide health-care providers in adapting protocols to the local constraints in developing countries.


Assuntos
Perda Auditiva/congênito , Perda Auditiva/epidemiologia , Triagem Neonatal/métodos , Países em Desenvolvimento , Potenciais Evocados Auditivos do Tronco Encefálico , Feminino , Perda Auditiva/diagnóstico , Humanos , Lactente , Recém-Nascido , Israel/epidemiologia , Jordânia/epidemiologia , Masculino , Emissões Otoacústicas Espontâneas , Prevalência , Fatores de Risco
2.
Cell Motil Cytoskeleton ; 33(1): 38-51, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8824733

RESUMO

Monoclonal antibodies were prepared against conserved synthetic peptide from the C-terminus of the gamma-tubulin and their specificity was confirmed by immunoblotting, competitive enzyme-linked immunosorbent assay (ELISA) and immunofluorescence. The antibodies decorated interphase centrosomes as well as half-spindles and midbodies in mitotic cells of various origin. The prepared antibodies were used to study the gamma-tubulin distribution in nocodazole and taxol-treated cells. In the cells recovering from the nocodazole treatment, gamma-tubulin was found in centers of all microtubule asters. Examination of relative location of gamma-tubulin and microtubule asters in taxol-treated mitotic cells 3T3, HeLa and PtK2 revealed that the number of taxol-induced microtubule asters exceeded the number of gamma-tubulin-positive spots. The gamma-tubulin was often found in the periphery of microtubule asters. Centrosomal phosphoprotein epitope detected by MPM-2 antibody colocalized with gamma-tubulin in taxol-treated mitotic cells. The presented data suggest that taxol-induced microtubule asters are in vivo nucleated independently of gamma-tubulin, and other minus-end nucleator(s) are necessary for formation of such asters. Alternatively, gamma-tubulin is present in subthreshold amounts undetectable by immunofluorescence.


Assuntos
Microtúbulos/metabolismo , Mitose , Paclitaxel/farmacologia , Tubulina (Proteína)/metabolismo , Células 3T3 , Sequência de Aminoácidos , Animais , Anticorpos Monoclonais/imunologia , Especificidade de Anticorpos , Células HeLa , Humanos , Macropodidae , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Nocodazol/farmacologia , Tubulina (Proteína)/imunologia , Células Tumorais Cultivadas , Turquia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...